Introduction
============

A major concern within health industries is some quantitative measure of mortality risk that may be faced by a member of population. Measures of mortality that only take the probability of death to represent risks faced by an individual do not take into account the timing of death and any discounting that may be present. Whereas, remaining life at risk, given life expectancies of individuals, are important in evaluating risks faced by the population as evidenced in the literature ([@b1-ijph-39-042]--[@b7-ijph-39-042]). Risk of death from different causes could be different due to the age of the individual exposed to such risks. Not all individuals, irrespective of their age, are subject to the same mortality risk from any cause. For example, death from a malignant neoplasm is far more likely to threaten the life of a 60 yr old than an infant is. While, congenital anomalies expose infants to higher risk that are almost nonexistent in older age groups.

The method for incorporating other information that affects measurement of risk as suggested in ([@b5-ijph-39-042]) takes into account factors other than just the probability of death. It includes life expectancies at different ages to represent the remaining life at risk for an individual. As individuals may face risks from different ailments, then the incorporation of life expectancies brings in some measure of the magnitude of risk that is ex-ante based on a number of years the individual is expected to live. Life expectancies are given from life tables, which extrapolate remaining lives for individuals in all ages up to 100. In order to have some quantitative measure of lives lost, the expected years of life lost (EYLL) which is in a statistical sense an expected value of each life lost, provide a measure of human life lost because of each death following exposure to a risk. This factor is mainly the reason why a reordering of major causes of death ranks, takes place. The implication for health and safety regulation thus follows from this reordering of ranks of the major causes of death. As pointed out in ([@b8-ijph-39-042]--[@b9-ijph-39-042]) in most health services industries, a greater portion of health expenditure falls on therapy, for a few who experience an ailment. Thus, substantial financial resources are devoted to a few who are identified with having a condition. Whereas the re-ordering of these major causes of death changes the way, health policy and regulation can be adopted. Thus, preventing or reducing the risk of these conditions for people who have not yet been diagnosed as having a particular condition. Of course, this is a major concern within the economics profession and the health industry to evaluate the costs and benefits of public resources and to suggest courses of action for policy making.

Finally, as many health risks take effect in time and so there is a period during which the individual appears healthy while symptoms of a condition has not shown itself, a time lag between exposure and incidence of death is considered. We also provide a lag response rate estimated for all major conditions and the results confirm those found in ([@b5-ijph-39-042]). However, we are aware that such lag responses are ad-hoc. Some conditions take effect without any time lag, as in most accidents. Thus, it is meaningless to consider a measure of risk that lags the effect of some condition with immediate death implications.

This paper is presented in three sections. Section one presents the model adopted in here with extensions to include birth rates. Section two presents the empirical findings in four tables. [Table 1](#t1-ijph-39-042){ref-type="table"} provides estimates for probability of death from major causes, life lost expectancies, expected years of life lost and the corresponding estimates that are discounted and then lagged. [Table 2](#t2-ijph-39-042){ref-type="table"} ranks these major conditions based on probability of death, life lost expectancies and expected years of life lost and provides evidence for the reordering that takes place because of this method of measuring mortality risks. [Tables 1](#t1-ijph-39-042){ref-type="table"} and [2](#t2-ijph-39-042){ref-type="table"} are estimates in eighteen groups of major conditions, thus aggregating the information that is provided in [Tables 3](#t3-ijph-39-042){ref-type="table"} and [4](#t4-ijph-39-042){ref-type="table"}. The aggregation will allow a comparison to be made in section three. [Table 3](#t3-ijph-39-042){ref-type="table"} is similar to [Table 2](#t2-ijph-39-042){ref-type="table"} except that the estimates are further sub-grouped in 150 headings. In Section three we calculate nonparametric tests for the existence of any shift in population distributions and find correlations in our mortality risk rankings for 1999 and 2000 data. Section four provides a comparison between our findings and those of the literature and concludes the study with further research suggestions.

Model specification
-------------------

We adopt the methodology in ([@b5-ijph-39-042]) and offer extensions. That is in calculating mortality risk measures, which in addition to the lifetime probability of death from any condition faced by an individual, takes into account the life expectancy of those individuals at every age (x). Individuals face different risks from a condition depending on their age. The magnitude of measures of lives lost is thus affected by both the probability of death from a condition at a particular age and the individual's life expectancy at that age. Therefore, the measures of mortality risk estimated in this way, changes the rank order of mortality risk in this model.

To be specific, a hypothetical cohort of *N*~0~ people born at time *t*= 0 are followed for *T* years. Survivors aged *t*, *S~t~* at the end of every time period are given by $$S_{t} = N_{0}\prod\limits_{t = 0}^{T}\left( {1 - \gamma_{t}} \right)$$Where *γ~t~* is the probability of death in time period t and for *N*~0~ people born at *t*=0, death at time *t* implies they died aged *t*. For a cohort this implies all individuals who die are *t* years old, i.e. *t*= *x* where *x* represents age. However, *D~jt~* = *γ~jt~* *S*~*t*−1~ where *γ~jt~* the probability of death is aged *t* from condition *j* faced by the members of the cohort. Published statistics also provide information about the number of *t*-year olds who have died from condition *j*. Thus in order to calculate lost life expectancy for each individual, we calculate *D~jt~l~t~* for each life lost. Then the average lost life expectancy LLE for all classified conditions are found from $$LLE_{j} = \left. {\sum\limits_{t = 0}^{T}{D_{jt}l_{t}}}/{\sum\limits_{t = 0}^{T}{D_{jt}\,\,\,\,\,\,\,\,\,\,\, j = 1,\cdots,J}} \right.$$Where *l~t~* represents life expectancy at age *t* and obtained from life tables. The information about life expectancies in our model is obtained from ([@b11-ijph-39-042]). While the estimates for expected years of life lost EYLL is obtained from $${EYLL}_{j} = p_{j}\left( {LLE_{j}} \right)\,\,\,\,\,\,\,\,\,\,\,\,\,\, j = 1,\cdots,J$$Where *p~j~* is the lifetime probability of death from an ailment. The estimated discounted and lagged values of \[[2](#FD2){ref-type="disp-formula"}\] and \[[3](#FD3){ref-type="disp-formula"}\] are obtained using standard calculus and are given by $$\mathit{disc}\,{LLE}_{j} = \frac{\left( {1 + i} \right)^{{LLE}_{j}} - 1}{i\left( {1 + i} \right)^{({LLE_{j} - 1})}}$$ $$\mathit{disc}\,{EYLL}_{j} = p_{j}\left( {\mathit{disc}\,\mathit{LL}E_{j}} \right)$$Where *i*, is the rate of discount and set to 3%, as in ([@b5-ijph-39-042]) and the results are presented in [Tables 1](#t1-ijph-39-042){ref-type="table"} and [3](#t3-ijph-39-042){ref-type="table"}. However, it is worth noting that this 3% rate of discounting is the best estimate available, although it is rather ad-hoc. The evidence to support this rate of time preference is based on the goodness of fit presented in a number of regressions that examine factors affecting mortality risk perceptions. But the rate of time preference as may be indicated by inter-temporal decisions of individuals needs a more extensive discussion ([@b3-ijph-39-042], [@b7-ijph-39-042], [@b8-ijph-39-042], [@b10-ijph-39-042]). In discussions involving environmental issues, the role of discount rate is central to cost-benefit analysis, but finding the "right" discount rate has always been problematic ([@b9-ijph-39-042]). In order to calculate lagged values of LLE and EYLL by *τ* years, equations in \[[4](#FD4){ref-type="disp-formula"}\] and \[[5](#FD5){ref-type="disp-formula"}\] are multiplied by (1 + *i*)*^τ^*. This will evaluate the corresponding deferred symptom factor that may be present in some health risks. While the medical indication to verify the length of time lag for each condition is not provided by published data, we have insufficient information to justify any length of time lag. Thus this ten-year lag is, once again, rather ad-hoc. At best, the statistical methodology of best fitting regressors to explain variations in dependent variable, namely risk perception, is not always "medically" accurate in reflecting the correct lag response between exposure and the incidence of death.

We also wish to make our theoretical model more accountable to the fact that population under study includes birth as well as death rates. We assume birth, death rates are uniform and equal throughout the year, and there is no immigration or emigration such that the population remains stable. Hypothetical cohorts that construct theoretical models with changing populations, allowing variation in birth and death rates, are found in the demographic literature as in ([@b12-ijph-39-042]). The analysis in this paper tries to include birth rates using component method used in demographic studies. Thus if we reconsider our cohort of *N*~0~ people and allow an inflow of newborns into this population, the above equations will change. Naturally, *D~t~* and *D~jt~* no longer represent the number of death, aged *t*, from all ailments and ailment *j,* correspondingly. However, *D~t~* and *D~jt~* represent the number who die in period *t*, where *t* is not necessarily equal to the age of the deceased. The information about the age of the dead is available in published statistics and we are able to estimate mortality measures taking age variations into account in the composition of our population due to an inflow of newborns. Suppose *M*~0~ is the best estimate of population at time *t= 0*. Let *D~t~* be the outflow from our sample i.e. the dead and *B~t~* represent the number of newborn i.e. the inflow. Survivors at the end of period *t*, can then be shown to equal $$S_{t} = M_{0}\prod\limits_{t = 0}^{T}\left( {1 - \gamma_{t} + \beta_{t}} \right)$$Where *β~t~* is the birth rate and *γ~t~* is the death rate in period *t* and $$\beta_{t} = \frac{B_{t}}{M_{t}},\,\,\,\,\,\,\,\gamma_{t} = \frac{D_{t}}{M_{t}}$$If however, we disallow the inflow of newborn in our population with *β~t~* = 0 in \[[6](#FD6){ref-type="disp-formula"}\] and assume a cohort in period *t*, we then obtain equation \[[2](#FD2){ref-type="disp-formula"}\] as a special case. Taking note of the fact that information about population statistics includes newborns, thus there is an inflow in the population as well as an outflow. Therefore, mortality measures are better represented in this way. The corresponding values of LLE in \[[2](#FD2){ref-type="disp-formula"}\], EYLL in \[[3](#FD3){ref-type="disp-formula"}\], the discounted and lagged values in \[[4](#FD4){ref-type="disp-formula"}\] and \[[5](#FD5){ref-type="disp-formula"}\] of our mortality measures follow from equation \[[6](#FD6){ref-type="disp-formula"}\]. But, the probability of death from a condition *j* in year *t* is found by $$p_{jt} = \frac{D_{jt}}{D_{t}}$$In addition, the lifetime probability of death for a condition is given by $$p_{j} = \sum\limits_{t = 1}^{T}p_{jt}$$Where the probability of death for *x* year olds from condition *j* is $$p_{jx} = \frac{D_{jx}}{D_{tx}}$$Where, *D~jx~* is the number of *x* year olds died from condition *j* and *D~tx~* is the number of *x* year olds died in period *t*. Here *p~jx~* is not equal to *p~jt~* unless we have a cohort.

However, not all births or deaths take place or are supervised under ministry run health centers. The underreporting of deaths may be more than births as they may involve expenses for the bereaved and not reporting may entail continuation of certain state benefits. Failure to report a birth or death has also legal and financial implications where beneficiaries of any left state, require official certification. Overall these records are representative of the population and the best available.

Empirical findings
------------------

In our model, data were obtained from official statistics as published in the Iranian Ministry of Health Mortality Tables Annual Almanac ([@b13-ijph-39-042]--[@b17-ijph-39-042]). These tables provide information about recorded deaths for 150 causes. Age at death is recorded and the statistics provide fourteen different age groups in which records are available. The classification also aggregates these 150 ailments into seventeen broader categories. This broad grouping enables us to make comparisons with other findings.

We present the first set of our findings in [Table 1](#t1-ijph-39-042){ref-type="table"} where seven measures are estimated in eighteen categories. The probability of death is found directly from data and represents the ratio of the number of deaths from a condition to total number in the sample. As such, it represents an ex-post estimate of a measure of risk that individuals may consider for any health condition. Therefore, the probabilities offer some magnitude of a health risk based on the existing recorded information and are a measure of risk after the event. The novelty of this model is in the comparison that is made between measures of risk that represent an ex-ante quantitative measure and those that are ex-post. LLE reflects a quantitative measure of lives lost, but subject to life expectancy of all individuals that are likely to be affected by a particular condition. It is therefore, conditional and weighted according to the number of years those individuals affected, might have expected to live. Thus, it offers an ex-ante quantitative measure of risk that is faced by a member of population. The EYLL is by definition the product of probability of death and LLE. It is therefore a weighted quantitative measure, which radically reorders mortality risk ranking. The rank orders are shown in [Tables 2](#t2-ijph-39-042){ref-type="table"} and [3](#t3-ijph-39-042){ref-type="table"}. As it is seen in [Table 2](#t2-ijph-39-042){ref-type="table"} Circulatory diseases are the most risky and ranks 1. Whereas according to the number of years of life lost, it ranks 17. This condition is in contrast with prenatal disorders that result in the highest years of life lost, since those affected are infants and expected to live much longer in the absence of the health risk. The rank orders according to LLE are highest for prenatal disorders and nearly the last for Circulatory diseases. As pointed out in ([@b8-ijph-39-042], [@b14-ijph-39-042]) a critical decision has to be made regarding public finances directed to health services and health insurance. The ranking here clearly indicates that any decision about funding and costing of medical care that is based on priorities, is dramatically affected by mortality risk measures adopted.

The order in [Table 3](#t3-ijph-39-042){ref-type="table"} to categorize ailments into diagnostically similar groups is made by the medical profession and does not reflect any risk attribute. The discounted values of LLE and EYLL are accordingly scaled down compared to the corresponding values of LLE and EYLL. Discounting LLE and EYLL are non-linear but monotonic. While at different ages, people have a different time horizon to discount their expected life, a higher LLE value will always lead to a higher discounted LLE without affecting the rank orders between risk factors. The lagged values in [Tables 1](#t1-ijph-39-042){ref-type="table"} and [3](#t3-ijph-39-042){ref-type="table"} further dampen down the effect of lives lost by a further lagged element. Hence values of lagged LLE and EYLL are smaller compared to the corresponding discounted and actual values of LLE and EYLL.

Some values in [Table 3](#t3-ijph-39-042){ref-type="table"} and [4](#t4-ijph-39-042){ref-type="table"} are starred. This is in order to avoid lagging the effect of any health risk that takes effect without any time delay such as in most accidents.

In [Table 3](#t3-ijph-39-042){ref-type="table"} there are also two categories that are not well defined 137 & 151: The "symptoms and other ill-defined conditions" plus "unspecified causes". As data stand, the amount of unexplained death probability is 0.04095 plus 0.0369 i.e. 0.07785 or 7.8% of all deaths. In order to see how demographic composition of this group may affect EYLL, a look at the age at death is helpful. For "symptoms and other ill-defined conditions" the largest count is 3221 out of a total 8679, which are in the 65+ age group. Perhaps due to old age, the significance of cause of death has been overlooked. While for the "unspecified causes", the largest count of 2968 out of a total 7820 is for aborted pregnancies. Again, perhaps due to a very early form of life, cause of death is overlooked. Raw data includes abortive deaths and stillbirths and it might be argued that these two categories should be excluded. However, taking an economic point of view, both of these categories impose a cost on people and health services and are therefore included in the calculations of EYLL.

We have also calculated EYLL for this 7.8% "unspecified" deaths based on age at death that is available for each record. Therefore, for the 215 death records for the age group 5--9 yr that were due to "symptoms and other ill-defined conditions" or just "unspecified" the calculated EYLL takes age composition into account.

The results in [Table 4](#t4-ijph-39-042){ref-type="table"} giving rank orders for an extensive list of medical conditions highlight how this model changes the priority that is attached to any ailment may be contrary to the perceived image. But it is quite clear how reordering is affecting priorities. The ranking based on the probability of death is quite markedly different from the LLE measure. The EYLL also offer a somewhat in between measure of mortality risk than the probability of death or LLE. It is also worth noting that aggregation also affect the ranking as it is seen in [Tables 2](#t2-ijph-39-042){ref-type="table"} and [4](#t4-ijph-39-042){ref-type="table"}. In [Table 2](#t2-ijph-39-042){ref-type="table"}, it is shown that heart conditions are the riskiest, while in [Table 4](#t4-ijph-39-042){ref-type="table"} the old age appears the most risky condition. This condition, i.e. senility (old age) is put in the "ill defined" category in [Table 2](#t2-ijph-39-042){ref-type="table"}, thus ranking second.

In addition to providing disaggregated information for the medical profession, [Table 4](#t4-ijph-39-042){ref-type="table"} may also provide indications as to the level of insurance coverage that may be needed. This can be seen by noting risks involved. The higher is the ranking, the higher insurance premium. However, discussions regarding the consequences of insurance premiums and cost-effectiveness of various decisions based on this reordering are beyond this study ([@b15-ijph-39-042]).

Estimations were carried out for year 2000 as data became available but the presentation of these results involves considerable length of tables that are avoided to save space (as in 18). However, we state that our findings for the year 2000 also confirm a reordering of mortality risks as presented in Section 2. However, we compare mortality risk ranks for the 2 yr and present them in Section 3.

3.. Tests
=========

Here we present the results of nonparametric tests with the intention of examining if there has been any tendency for the data to shift between these two years. This is done using the Mann-Whitney U test, which detects shifts in the distribution of our mortality risk ranking. The results presented in section 2 enable us to examine ranks using nonparametric methods. We have ranks of various mortality risk measures and we wish to know if mortality risk ranking is significantly different between these two years. Differences between these two mortality data could be in the form of a shift among various causes of death between the two years. Ranks of some causes may have changed and therefore we would like to know if there are any significant changes in mortality risk ranking. Since we are dealing with ranks, nonparametric tests are used. Procedures to carry out these tests are found in many statistical texts as in (16--19).

The Mann-Whitney U test for a change in the location of population distribution is calculated and the results are shown in [Table 5](#t5-ijph-39-042){ref-type="table"}. We have also calculated the Spearmen rank correlation coefficient to test the strength of association between the two mortality risk rankings. For the Spearman rank correlation coefficient the null hypothesis *H*~0~ is that the observed ranks of mortality risks in 1999 and 2000 are positively correlated against the alternative *H*~1~ that they are independent, hence there has been no significant change in ranks. For Mann-Whitney U test, the null hypothesis *H*~0~ is that there has been no change in mortality risk ranking from 1999 to 2000 against the alternative *H*~1~ that there has been a shift in the distribution of mortality risk rankings.

The test statistic to take account of large samples is $z = r_{s}\sqrt{J - 1}$ where *r~s~* represent the Spearman rank correlation coefficient. However, the smaller value of 0.6861 for the Spearman rank correlation coefficient for LLE compared with the corresponding values of probability and EYLL indicates that there seems to be some variation in the age composition of death frequencies with probabilities of deaths remaining unchanged. This may be clearer by considering equation \[[2](#FD2){ref-type="disp-formula"}\]. The interpretation is in the number of death frequencies for infants and childhood diseases that affect LLE. The LLE seem to show some variation from year to year. But, this variation does not seem to be carried through to the EYLL. The reason, we think would have to be in the properties of non-parametric statistics. EYLL is found through a non-linear operation (*p~j~* (*LLE~j~*)), whereas ranking is a linear comparison that does not take into account the size of the difference between any two adjacent numbers. Only their relative size is important. Ranking LLE, EYLL and probability does not take into account what these numbers are explaining or are about. The fact that probabilities vary from 0 to 1 (in [Table 4](#t4-ijph-39-042){ref-type="table"} from 0 to 0.16704) and that LLE vary from 0 to 66.77 i.e. the concentration or dispersion of these numbers, has nothing to do with their rank. Consequently, their product could provide a different ranking not necessarily showing any systematic dominance of either probability or LLE. As an example from [Table 4](#t4-ijph-39-042){ref-type="table"}, "Other causes of prenatal morbidity and mortality" probability ranks 6 and LLE ranks 5, but EYLL ranks first. Taking another example at the bottom of the [Table 4](#t4-ijph-39-042){ref-type="table"}, we see that conditions "Anthrax" and "Schistosomiasis" rank 140 in probability, but the LLE's are 78 and 71 while the corresponding EYLL have remained unchanged at 140. While for "Erysipelas" that has probability rank of 140 and LLE rank of 140, the corresponding EYLL rank is 144.

The EYLL measure of risk averages somewhat non-linearly the information content of LLE and probability of death. The weights that are given to each element in this product are unity, i.e. giving equal weight to each, but distributions are different. *p~j~* varies from 0 to 0.16704 (theoretically 0 to 1) and LLE is distributed from 0 to 66.77 (hypothetically up to 100 yr). Thus EYLL is a measure of risk that tells us, in a non-linear way, how much risk there is in every condition in terms of so many probable life years.

In order to test for correlation in the ranks of mortality risks we use a large sample approximation (20). Our data includes 151 pairs of observations, thus z scores are calculated which are approximately distributed as standard normal. If both *r* and *r~s~* in [Table 5](#t5-ijph-39-042){ref-type="table"} were to be considered, they show very significant positive correlation between mortality risk ranks. The values are statistically significant at 0.001level. The z scores which are approximately N (0,1), are significant. The probability of a *z*= 4 is 0.99997 see (21). Thus, we could not reject the null hypothesis of positive correlation between 1999 and 2000 mortality risk rankings and the two sets of risk rankings are highly correlated. With the Mann-Whitney U test in [Table 5](#t5-ijph-39-042){ref-type="table"} we do not reject the null hypothesis and thus conclude that there were no shifts within the distribution of our mortality risk rankings. The results are statistically significant at 0.05 level. The test results in this section indicate that mortality risk measures offered in section 2 are stable across the two. Thus, these risk measures are robust across time and relay risk information consistently.

Conclusion
==========

This study emphasizes the significance of considering measures of mortality risk that take into account life expectancies at different ages as well as discounted and lagged symptom effects. Our results confirm findings in ([@b5-ijph-39-042], [@b18-ijph-39-042]) that a major reordering of mortality risk ranks takes place once we allow for the risk weighting measures. The most significant risks facing the population in both studies are heart conditions. Cancer also appears ranking high in ([@b5-ijph-39-042]) as in here. Nevertheless, aggregation and classification of health conditions make comparison difficult between this study and others. The results of nonparametric tests in Section 3, confirms that the risk rankings have remained the same for the two years.

However, it has not been possible to see how public regulations could change mortality risk rankings in Iran. It has not been possible to find the corresponding regulations and the relevant data. Such impacts and their research are thought to occupy future research and we hope that this study may provide some encouragement in that respect.
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###### 

Mortality risks for major conditions

  **Condition**                                                **Prob**   **LLE**         **EYLL**   **Disc LLE**   **Disc EYLL**   **Lag LLE**                                         **Lag EYLL**
  ------------------------------------------------------------ ---------- --------------- ---------- -------------- --------------- --------------------------------------------------- --------------------------------------------------
  Infectionus and parasitic diseases                           0.0156     35.81 (4.16)    0.56       22.42          0.35            16.68                                               0.26
  Neoplasm (Cancer)                                            0.0905     17.89 (1.17)    1.62       14.1           1.28            10.49                                               0.95
  Endocrine, nutritional and metabolic disease                 0.0108     21.29 (1.7)     0.23       16.04          0.17            11.93                                               0.13
  Blood disorders and blood forming organs                     0.0048     38.41 (3.42)    0.18       23.3           0.11            17.34                                               0.08
  Mental disorders                                             0.0056     40.37 (2.22)    0.22       23.92          0.13            17.8                                                0.1
  Disorders of the nervous system                              0.0057     33.09 (1.79)    0.19       21.42          0.12            15.94                                               0.09
  Diseases of the circulatory system                           0.3549     14.1 (1.27)     5.01       11.71          4.15            8.71                                                3.09
  Diseases of the respiratory system                           0.0351     23.98 (2.6)     0.84       17.43          0.61            12.97                                               0.45
  Diseases of the digestive system                             0.0237     20.02 (0.91)    0.47       15.34          0.36            11.41                                               0.27
  Genitourinary disorders                                      0.0138     18.45 (1.0)     0.26       14.43          0.2             10.74                                               0.15
  Complications of pregnancy, child birth and the puerperium   0.0007     38.62(4.91)     0.03       23.37          0.02            23.37[\*](#tfn1-ijph-39-042){ref-type="table-fn"}   0.02[\*](#tfn1-ijph-39-042){ref-type="table-fn"}
  Skin and sub-tissue disorders                                0.0005     31.61 (2.75)    0.01       20.84          0.01            15.51                                               0.01
  Diseases of the musculoskeletal system                       0.0011     27.77 (1.07)    0.03       19.23          0.02            14.31                                               0.02
  Congenital anomalies                                         0.0289     62.71 (15.96)   1.81       28.95          0.84            21.55                                               0.62
  Prenatal disorders                                           0.0482     65.07 (18.78)   3.13       29.32          1.41            21.81                                               1.05
  Accidents and poisoning                                      0.1153     38.06 (2.35)    4.39       23.19          2.67            17.25                                               1.99
  Ill defined conditions (old age)                             0.1671     7.31 (1.86)     1.22       6.67           1.12            6.67[\*](#tfn1-ijph-39-042){ref-type="table-fn"}    1.12[\*](#tfn1-ijph-39-042){ref-type="table-fn"}
  Unspecified                                                  0.0779     33.5 (5.21)     2.61       21.58          1.68            21.58[\*](#tfn1-ijph-39-042){ref-type="table-fn"}   1.68[\*](#tfn1-ijph-39-042){ref-type="table-fn"}

Notes: Prob denotes probability of death, LLE denotes Lost Life Expectancy with corresponding standard errors in brackets, EYLL denotes Expected Years of Life Lost, Disc LLE and Disc EYLL incorporate a 3% annual discount rate. Lag LLE and lag EYLL take ten-year lags into account between exposure to an illness and the incidence of death. For entries that are not lagged,

indicates values of the corresponding Disc LLE and Disc EYLL have been carried over.

###### 

Rank order of mortality risks for major conditions

  **Condition**                                                **Rank**                                                              
  ------------------------------------------------------------ ---------- ---- ---- ------------------------------------------------ ------------------------------------------------
  Diseases of the circulatory system                           1          17   14   1                                                17
  Ill defined conditions (old age)                             2          18   11   6[\*](#tfn2-ijph-39-042){ref-type="table-fn"}    18[\*](#tfn2-ijph-39-042){ref-type="table-fn"}
  Accidents and poisoning                                      3          6    9    2                                                7
  Neoplasm (Cancer)                                            4          16   15   5                                                16
  Unspecified                                                  5          8    3    3[\*](#tfn2-ijph-39-042){ref-type="table-fn"}    3[\*](#tfn2-ijph-39-042){ref-type="table-fn"}
  Prenatal disorders                                           6          1    1    4                                                2
  Diseases of the respiratory system                           7          12   8    8                                                12
  Congenital anomalies                                         8          2    2    7                                                4
  Diseases of the digestive system                             9          14   18   9                                                14
  Infectious and parasitic diseases                            10         7    5    10                                               8
  Genitourinary disorders                                      11         15   17   11                                               15
  Endocrine, nutritional and metabolic disease                 12         13   13   12                                               13
  Disorders of the nervous system                              13         9    12   14                                               9
  Mental disorders                                             14         3    10   13                                               5
  Blood disorders and blood forming organs                     15         5    6    15                                               6
  Diseases of the musculoskeletal system                       16         11   16   16                                               11
  Complications of pregnancy, child birth and the puerperium   17         4    4    16[\*](#tfn2-ijph-39-042){ref-type="table-fn"}   1[\*](#tfn2-ijph-39-042){ref-type="table-fn"}
  Skin and sub-tissue disorders                                18         10   7    18                                               10

Notes: For entries marked with

values of the corresponding Disc LLE and Disc EYLL were not lagged.

###### 

Mortality risks for 150 conditions

        **Condition**                                                            **Prob**   **LLE**         **EYLL**   **Disc LLE**   **Disc EYLL**   **Lag LLE**                                         **Lag EYLL**
  ----- ------------------------------------------------------------------------ ---------- --------------- ---------- -------------- --------------- --------------------------------------------------- ----------------------------------------------------
  1     Cholera                                                                  0.00012    36.03 (3.98)    0.0044     22.5           0.0028          16.74                                               0.0021
  2     Typhoid fever                                                            0.00022    21.33 (1.12)    0.0047     16.06          0.0036          11.95                                               0.0026
  3     Paratyphoid fever & other salmonella infections                          0.00015    43.1 (5.51)     0.0063     24.73          0.0036          18.4                                                0.0027
  4     Bacillary dysentery and amoebiasis                                       0.00022    48.27 (5.93)    0.0107     26.09          0.0058          19.41                                               0.0043
  5     Enteritis and other diarrhoeal diseases                                  0.00189    53.81 (9.7)     0.1018     27.34          0.0517          20.34                                               0.0385
  6     Tuberculosis of respiratory system                                       0.00101    17.46 (1.31)    0.0176     13.84          0.014           10.3                                                0.0104
  7     Tuberculosis of meninges and central nervous system                      0.00027    19.67 (2.38)    0.0054     15.14          0.0041          11.26                                               0.0031
  8     Tuberculosis of intestines peritoneum and mesenteric glands              0.00014    26.25 (1.38)    0.0036     18.53          0.0025          13.79                                               0.0019
  9     Tuberculosis of bones and joints                                         0.00012    23.95 (1.84)    0.0028     17.42          0.0021          12.96                                               0.0015
  10    Other tuberculosis including late effects                                0.00037    20.67 (1.1)     0.0076     15.69          0.0058          11.68                                               0.0043
  11    Plague                                                                   0          0               0          0              0               0                                                   0
  12    Anthrax                                                                  0.00001    27.13 (5.62)    0.0004     18.94          0.0003          14.09                                               0.0002
  13    Brucellosis                                                              0.00008    32.43 (2.36)    0.0024     21.17          0.0016          15.75                                               0.0012
  14    Leprosy                                                                  0.0001     31.41 (6.25)    0.0031     20.76          0.0021          15.45                                               0.0015
  15    Diphtheria                                                               0.00013    61.3 (16.26)    0.0081     28.72          0.0038          21.37                                               0.0028
  16    Whooping cough                                                           0.0002     13.4 (1.7)      0.0027     11.23          0.0023          8.35                                                0.0017
  17    Streptococcal sore throat and acarlet fever                              0.00018    42.86 (2.88)    0.0077     24.66          0.0044          18.35                                               0.0033
  18    Erysipelas                                                               0.00001    11.71 (2.5)     0.0001     10.04          0.0001          7.47                                                0.0001
  19    Meningococcal infection                                                  0.00004    34.63 (3.64)    0.0015     22             0.0009          16.37                                               0.0007
  20    Tetanus                                                                  0.00008    47.78 (8.12)    0.0041     25.97          0.0022          19.32                                               0.0016
  21    Other bacterial diseases                                                 0.00133    18.36 (1.19)    0.0243     14.38          0.0191          10.7                                                0.0142
  22    Acute poliomyelitis                                                      0.00008    41.83 (3.89)    0.0036     24.36          0.0021          18.13                                               0.0015
  23    Late effect of acute poliomyelitis                                       0.00007    44.19 (4.13)    0.0029     25.03          0.0017          18.63                                               0.0012
  24    Smallpox                                                                 0          0               0          0              0               0                                                   0
  25    Measles                                                                  0.00012    43.95 (3.73)    0.0054     24.97          0.0031          18.58                                               0.0023
  26    Yellow fever                                                             0          0               0          0              0               0                                                   0
  27    Viral encephalitis                                                       0.00028    41.6 (4.76)     0.0118     24.29          0.0069          18.08                                               0.0051
  28    Infectious hepatitis                                                     0.00165    36.81 (3.69)    0.0606     22.77          0.0375          16.94                                               0.0279
  29    Other viral diseases                                                     0.00026    41.45 (4.57)    0.011      24.25          0.0064          18.04                                               0.0048
  30    Typhus and other rickettsioses                                           0          0               0          0              0               0                                                   0
  31    Malaria                                                                  0.00008    26.86 (3.58)    0.0022     18.81          0.0015          14                                                  0.0011
  32    Trypanosomiasis                                                          0          0               0          0              0               0                                                   0
  33    Relapsing fever                                                          0          0               0          0              0               0                                                   0
  34    Congenital syphilis                                                      0          48.65(14.04)    0.0002     26.18          0.0001          19.48                                               0.0001
  35    Early syphilis, symptomatic                                              0          66.11(19.08)    0.0003     29.47          0.0001          21.93                                               0.0001
  36    Syphilis of central nervous system                                       0.00007    18.21 (2.06)    0.0012     14.29          0.0009          10.63                                               0.0007
  37    Other syphilis                                                           0.00005    14.51 (2.68)    0.0008     11.97          0.0006          8.91                                                0.0005
  38    Gonococcal infections                                                    0.00004    18.33 (3.1)     0.0007     14.36          0.0005          10.69                                               0.0004
  39    Schistosomiasis                                                          0.00001    29.67 (5.8)     0.0004     20.05          0.0003          14.92                                               0.0002
  40    Hydatidosis                                                              0.0001     23.79 (2.53)    0.0024     17.34          0.0017          12.9                                                0.0013
  41    Filarial infection                                                       0.00002    27.71 (4.48)    0.0007     19.2           0.0005          14.28                                               0.0003
  42    Ancylostomiasis                                                          0.00015    53.51 (7.19)    0.0081     27.27          0.0041          20.29                                               0.0031
  43    Other helminthiasis                                                      0.00027    45.33 (5.25)    0.0122     25.34          0.0068          18.86                                               0.0051
  44    All other infective and parasitic diseases                               0.0056     38.04 (5.05)    0.2131     23.18          0.1298          17.25                                               0.0966
  45    Malignant neoplasm of buccal cavity & pharynx                            0.00057    16.25 (1.49)    0.0092     13.09          0.0074          9.74                                                0.0055
  46    Malignant neoplasm of esophagus                                          0.00397    13.38 (1.47)    0.0531     11.21          0.0445          8.34                                                0.0331
  47    Malignant neoplasm of stomach                                            0.017      13.86 (1.44)    0.2356     11.54          0.1962          8.59                                                0.146
  48    Malignant neoplasm of intestine, except rectum                           0.0033     17.18 (1.36)    0.0567     13.67          0.0451          10.17                                               0.0336
  49    Malignant neoplasm of rectum & recto-sigmoid junction                    0.00035    16.13 (1.66)    0.0056     13.02          0.0045          9.69                                                0.0034
  50    Malignant neoplasm of larynx                                             0.00222    14.13(1.45)     0.0313     11.72          0.026           8.72                                                0.0193
  51    Malignant neoplasm of trachea, bronchus & lung                           0.00881    13.76 (1.43)    0.1212     11.47          0.1011          8.54                                                0.0752
  52    Malignant neoplasm of bone                                               0.00148    26.02 (1.48)    0.0384     18.42          0.0272          13.71                                               0.0202
  53    Malignant neoplasm of skin                                               0.00092    17.06 (1.26)    0.0157     13.6           0.0125          10.12                                               0.0093
  54    Malignant neoplasm of breast                                             0.00286    21.45 (2.39)    0.0614     16.12          0.0462          11.99                                               0.0344
  55    Malignant neoplasm of cervix uteri                                       0.0008     16.27 (1.84)    0.013      13.11          0.0105          9.75                                                0.0078
  56    Other malignant neoplasm of uterus                                       0.00085    20.17 (2.04)    0.0172     15.42          0.0132          11.47                                               0.0098
  57    Malignant neoplasm of prostate                                           0.00239    9.58 (1.6)      0.0229     8.47           0.0202          6.3                                                 0.015
  58    Malignant neoplasm of other and unspecified sites                        0.02961    18.7 (1.15)     0.5537     14.58          0.4317          10.85                                               0.3212
  59    Leukemia                                                                 0.00819    29.01 (1.22)    0.2376     19.77          0.1619          14.71                                               0.1205
  60    Other neoplasm of lymphatic & haemotopoietic tissue                      0.00256    22.45 (0.94)    0.0574     16.65          0.0426          12.39                                               0.0317
  61    Benign neoplasm & neoplasm of unspecified nature                         0.00458    19.14 (1.09)    0.0877     14.84          0.068           11.04                                               0.0506
  62    Non-toxic goitre                                                         0.00021    36.52 (3.47)    0.0078     22.67          0.0048          16.87                                               0.0036
  63    Thyrotoxicosis with or without goitre                                    0.0001     24.47 (2.2)     0.0024     17.68          0.0018          13.15                                               0.0013
  64    Diabetes mellitus                                                        0.00685    14.72 (1.29)    0.1009     12.11          0.083           9.01                                                0.0618
  65    Avitaminoses and other nutritional deficiency                            0.00113    55.3 (11.78)    0.0624     27.64          0.0312          20.57                                               0.0232
  66    Other endocrine and metabolic diseases                                   0.00249    22.53 (1.27)    0.0561     16.7           0.0416          12.42                                               0.0309
  67    Anemia                                                                   0.00129    48.08 (4.11)    0.0619     26.04          0.0335          19.38                                               0.025
  68    Other diseases of blood and blood-forming organs                         0.00349    34.84 (3.31)    0.1215     22.07          0.077           16.42                                               0.0573
  69    Psychoses                                                                0.00116    28.8 (1.47)     0.0333     19.68          0.0227          14.64                                               0.0169
  70    Neuroses, personality disorders & other non-psychotic mental disorders   0.00159    28.47 (0.98)    0.0451     19.54          0.031           14.54                                               0.023
  71    Mental retardation                                                       0.00282    51.8 (3.94)     0.1462     26.91          0.0759          20.02                                               0.0565
  72    Meningitis                                                               0.00103    43.63 (3.63)    0.0449     24.88          0.0256          18.51                                               0.019
  73    Multiple sclerosis                                                       0.00117    19.63 (1.24)    0.023      15.11          0.0177          11.25                                               0.0132
  74    Epilepsy                                                                 0.00134    44.16 (2.97)    0.059      25.03          0.0334          18.62                                               0.0249
  75    Inflammatory diseases of eye                                             0.00007    16.5 (1.91)     0.0012     13.25          0.0009          9.86                                                0.0007
  76    Cataract                                                                 0.00005    13.99 (1.81)    0.0007     11.63          0.0006          8.65                                                0.0004
  77    Glaucoma                                                                 0.00005    20.21(2.81)     0.001      15.44          0.0007          11.49                                               0.0005
  78    Otitis media and mastoiditis                                             0.00013    18.21 (1.49)    0.0024     14.29          0.0019          10.63                                               0.0014
  79    Other diseases of nervous system and sense organs                        0.00185    30.32 (1.77)    0.0562     20.32          0.0377          15.12                                               0.028
  80    Active rheumatic fever                                                   0.00015    36.87 (2.74)    0.0054     22.79          0.0033          16.96                                               0.0025
  81    Chronic rheumatic heart disease                                          0.00055    18.97 (1.22)    0.0105     14.73          0.0081          10.96                                               0.0061
  82    Hypertensive disease                                                     0.00696    11.25 (1.48)    0.0783     9.72           0.0676          7.23                                                0.0503
  83    Ischaemic heart disease                                                  0.09818    13.57 (1.35)    1.3322     11.34          1.1138          8.44                                                0.8287
  84    Other forms of heart disease                                             0.16409    14.05 (1.28)    2.3061     11.67          1.9151          8.68                                                1.425
  85    Cerebovascular disease                                                   0.06621    14.32 (1.22)    0.9479     11.85          0.7843          8.81                                                0.5836
  86    Diseases of arteries arterioles & capillaries                            0.00269    16.26 (1.12)    0.0437     13.1           0.0352          9.75                                                0.0262
  87    Venous thrombosis and embolism                                           0.00589    15.39 (1.23)    0.0906     12.55          0.0739          9.34                                                0.055
  88    Other diseases of circulatory system                                     0.01007    18.81 (0.93)    0.1894     14.65          0.1475          10.9                                                0.1097
  89    Acute respiratory infection                                              0.00385    42.31 (7.47)    0.1631     24.5           0.0945          18.23                                               0.0703
  90    Influenza                                                                0.00022    38.82 (4.23)    0.0086     23.43          0.0052          17.44                                               0.0039
  91    Viral pneumonia                                                          0.00174    28.37 (3.67)    0.0494     19.49          0.0339          14.5                                                0.0252
  92    Other pneumonia                                                          0.00337    32.46 (4.6)     0.1094     21.18          0.0714          15.76                                               0.0531
  93    Bronchitis, emphysema and asthma                                         0.00838    13.9 (1.29)     0.1166     11.57          0.097           8.61                                                0.0722
  94    Hypertrophy of tonsils and adenoids                                      0.00023    31.29 (2.53)    0.0071     20.72          0.0047          15.42                                               0.0035
  95    Emphysema and abscess of lung                                            0.00153    16.53 (1.16)    0.0253     13.27          0.0203          9.88                                                0.0151
  96    Other diseases of respiratory system                                     0.01572    22.96 (2.35)    0.361      16.92          0.266           12.59                                               0.1979
  97    Diseases of teeth and supporting structures                              0.00003    37.33 (5.98)    0.0012     22.94          0.0008          17.07                                               0.0006
  98    Peptic ulcer                                                             0.00035    17.05 (1.16)    0.006      13.59          0.0048          10.11                                               0.0036
  99    Gastritis and duodenitis                                                 0.00068    16.77 (1.39)    0.0115     13.42          0.0092          9.98                                                0.0068
  100   Appendicitis                                                             0.00037    34.03 (1.92)    0.0125     21.78          0.008           16.2                                                0.006
  101   Intestinal obstruction and hernia                                        0.00068    27.75 (3.86)    0.0189     19.22          0.0131          14.3                                                0.0097
  102   Cirrhosis of liver                                                       0.00537    20.08 (1.12)    0.1078     15.37          0.0825          11.44                                               0.0614
  103   Cholelithiasis and cholecystitis                                         0.00062    16.55 (1.17)    0.0103     13.28          0.0083          9.88                                                0.0062
  104   Other diseases of digestive system                                       0.01559    19.64 (0.89)    0.3061     15.12          0.2357          11.25                                               0.1754
  105   Acute nephritis                                                          0.00053    18.72 (1.15)    0.01       14.59          0.0078          10.86                                               0.0058
  106   Other nephritis and nephrosis                                            0.00148    17.35 (1.11)    0.0256     13.77          0.0203          10.25                                               0.0151
  107   Infections of kidney                                                     0.00641    20.09 (0.94)    0.1287     15.38          0.0985          11.44                                               0.0733
  108   Calculus of urinary system                                               0.00017    17.56 (1.78)    0.0029     13.9           0.0023          10.35                                               0.0017
  109   Hyperplasia of prostate                                                  0.00026    9.16 (1.66)     0.0024     8.14           0.0021          6.06                                                0.0016
  110   Diseases of breast                                                       0.00004    18.4 (2.55)     0.0008     14.4           0.0006          10.72                                               0.0005
  111   Other diseases of genito-urinary system                                  0.00495    17.13 (1.09)    0.0848     13.64          0.0675          10.15                                               0.0502
  112   Toxaemias of pregnancy and the puerperium                                0.00003    38.91 (4.29)    0.0011     23.46          0.0007          17.46                                               0.0005
  113   Haemorrohage of pregnancy and childbirth                                 0.00017    40.69 (5.77)    0.0069     24.02          0.0041          24.02[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0041[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  114   Abortion induced for legal indications                                   0          6.84 (1.97)     0          6.28           0               6.28[\*](#tfn3-ijph-39-042){ref-type="table-fn"}    0[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  115   Other and unspecified abortion                                           0.00014    42.98 (6.0)     0.0059     24.7           0.0034          24.7[\*](#tfn3-ijph-39-042){ref-type="table-fn"}    0.0034[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  116   Sepsis of childbirth and the puerperium                                  0.00008    31.4 (3.14)     0.0024     20.76          0.0016          20.76[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0016[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  117   Other complication of pregnancy, childbirth and the puerperium           0.00025    37.84 (5.32)    0.0095     23.11          0.0058          23.11[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0058[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  118   Delivery without mention of complication                                 0.00002    35.9 (4.44)     0.0008     22.45          0.0005          22.45[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0005[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  119   Infections of skin and subcutaneous tissue                               0.0002     24.16 (2.5)     0.0048     17.52          0.0035          13.04                                               0.0026
  120   Other diseases of skin and subcutaneous tissue                           0.00025    37.4 (3.33)     0.0095     22.97          0.0059          17.09                                               0.0044
  121   Arthritis & spondylitis                                                  0.00012    14.85 (1.67)    0.0018     12.2           0.0014          9.08                                                0.0011
  122   Non-articular rheumatism and rheumatism unspecified                      0.00013    19.81 (1.49)    0.0025     15.21          0.0019          11.32                                               0.0014
  123   Osteomyelitis and periostitis                                            0.00006    39.14 (3.14)    0.0024     23.54          0.0014          17.51                                               0.0011
  124   Ankylosis and acquired musculoskeletal deformities                       0.00003    33.88 (4.8)     0.0011     21.72          0.0007          16.16                                               0.0005
  125   Other diseases of musculoskeletal system and connective tissue           0.00081    29.81 (1.17)    0.024      20.11          0.0162          14.96                                               0.0121
  126   Spina bifidia                                                            0.00016    33.01 (6.22)    0.0051     21.39          0.0033          15.92                                               0.0025
  127   Congenital anomalies of heart                                            0.0037     62.91 (14.55)   0.233      28.99          0.1074          21.57                                               0.0799
  128   Other congenital anomalies of circulatory system                         0.0011     59.81 (13.08)   0.0658     28.47          0.0313          21.19                                               0.0233
  129   Cleft palate and cleft lip                                               0.00015    66.11 (19.08)   0.01       29.47          0.0044          21.93                                               0.0033
  130   All other congenital anomalies                                           0.02377    62.99 (16.38)   1.4974     29             0.6893          21.58                                               0.5129
  131   Birth injury and difficult labour                                        0.00263    65.88 (19.02)   0.1734     29.44          0.0775          29.44[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0775[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  132   Conditions of placenta and cord                                          0.00127    62.98 (18.16)   0.0802     29             0.0369          29[\*](#tfn3-ijph-39-042){ref-type="table-fn"}      0.0369[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  133   Haemolytic disease of newborn                                            0.00274    66.11 (19.08)   0.1809     29.47          0.0806          29.47[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0806[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  134   Anoxic and hypoxic conditions not elsewhere classified                   0.00206    64.62 (18.65)   0.1332     29.25          0.0603          21.76                                               0.0449
  135   Other causes of prinatal morbidity and mortality                         0.03943    65.03 (18.77)   2.5641     29.31          1.1557          21.81                                               0.8599
  136   Senility without mention of psychosis                                    0.16704    7.31 (1.86)     1.2213     6.67           1.1147          6.67[\*](#tfn3-ijph-39-042){ref-type="table-fn"}    1.1147[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  137   Symptoms and other ill-defined conditions                                0.04095    25.39 (1.43)    1.0399     18.12          0.7422          18.12[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.7422[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  138   Motor vehicle accidents                                                  0.02723    37.12 (2.23)    1.0108     22.87          0.6228          22.87[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.6228[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  139   Other transport accidents                                                0.00999    37.04 (2.17)    0.3702     22.85          0.2283          22.85[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.2283[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  140   Accidental poisoning                                                     0.00557    36.88 (2.15)    0.2053     22.79          0.1269          22.79[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.1269[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  141   Accidental falls                                                         0.00309    34.8 (1.64)     0.1074     22.06          0.0681          22.06[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0681[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  142   Accidents caused by fires                                                0.00925    42.24 (3.35)    0.3907     24.48          0.2264          24.48[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.2264[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  143   Accidental drowning and submersion                                       0.00655    48.45 (3.53)    0.3173     26.13          0.1712          26.13[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.1712[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  144   Accidents caused by firearm missiles                                     0.00271    41.89 (4.21)    0.1137     24.38          0.0661          24.38[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0661[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  145   Accidents mainly of industrial type                                      0.00111    43.21 (3.05)    0.0479     24.76          0.0275          24.76[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0275[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  146   All other accidents                                                      0.02329    34.83 (1.91)    0.811      22.07          0.5139          22.07[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.5139[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  147   Suicide and self inflicted injury                                        0.00848    40.23 (4.26)    0.3413     23.88          0.2026          23.88[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.2026[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  148   Homicide and injury purposely inflicted by intervention                  0.0049     38.18 (3.31)    0.187      23.23          0.1138          23.23[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.1138[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  149   Injury undetermined whether accidentally or purposely inflicted          0.01083    36.33 (2.12)    0.3936     22.6           0.2449          22.6[\*](#tfn3-ijph-39-042){ref-type="table-fn"}    0.2449[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  150   Injury resulting from operations of war                                  0.00218    39.58 (3.42)    0.0861     23.68          0.0515          23.68[\*](#tfn3-ijph-39-042){ref-type="table-fn"}   0.0515[\*](#tfn3-ijph-39-042){ref-type="table-fn"}
  151   Unspecified causes                                                       0.0369     42.5 (9.67)     1.5683     24.56          0.9062          18.27                                               0.6743

Notes: For entries that are not lagged,

\* indicates values of the corresponding Disc LLE and Disc EYLL have been carried over.

###### 

Rank orders of mortality risks for 150 conditions

  **Condition**                                                            **Rank**                                                                 
  ------------------------------------------------------------------------ ---------- ----- ----- ------------------------------------------------- -------------------------------------------------
  Senility without mention of psychosis                                    1          144   6     142[\*](#tfn4-ijph-39-042){ref-type="table-fn"}   2[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other forms of heart disease                                             2          132   2     132                                               1
  Ischaemic heart disease                                                  3          137   5     137                                               4
  Cerebrovascular disease                                                  4          130   9     130                                               8
  Symptoms and other ill-defined conditions                                5          82    7     48[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    5[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other causes of prenatal morbidity and mortality                         6          5     1     23                                                3
  Unspecified causes                                                       7          30    3     45                                                6
  Malignant neoplasm of other and unspecified sites                        8          105   11    105                                               11
  Motor vehicle accidents                                                  9          48    8     14[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    7[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  All other congenital anomalies                                           10         7     4     25                                                10
  All other accidents                                                      11         58    10    19[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    9[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Malignant neoplasm of stomach                                            12         135   20    135                                               19
  Other diseases of respiratory system                                     13         87    15    87                                                16
  Other diseases of digestive system                                       14         99    18    99                                                17
  Injury undetermined whether accidentally or purposely inflicted          15         54    12    17[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    12[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other diseases of circulatory system                                     16         103   24    103                                               23
  Other transport accidents                                                17         49    14    15[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    13[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Accidents caused by fires                                                18         32    13    7[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     14[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Malignant neoplasm of trachea, bronchus & lung                           19         136   33    136                                               28
  Suicide and self inflicted injury                                        20         38    16    10[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    15[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Bronchitis, emphysema and asthma                                         21         134   34    134                                               30
  Leukaemia                                                                22         72    19    73                                                21
  Hypertensive disease                                                     23         141   46    141                                               42
  Diabetes mellitus                                                        24         128   40    128                                               34
  Accidental drowning and submersion                                       25         17    17    4[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     18[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Infections of kidney                                                     26         95    31    95                                                29
  Venous thrombosis and embolism                                           27         126   41    126                                               38
  All other infective and parasitic diseases                               28         44    22    54                                                24
  Accidental poisoning                                                     29         50    23    16[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    20[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Cirrhosis of liver                                                       30         96    37    95                                                35
  Other diseases of genito-urinary system                                  31         115   44    115                                               43
  Homicide and injury purposely inflicted by intervention                  32         43    25    12[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    22[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Benign neoplasm & neoplasms of unspecified nature                        33         101   42    101                                               41
  Malignant neoplasm of oesophagus                                         34         139   57    139                                               49
  Acute respiratory infection                                              35         31    28    46                                                31
  Congenital anomalies of heart                                            36         9     21    26                                                26
  Other diseases of blood and blood-forming organs                         37         57    32    61                                                36
  Other pneumonia                                                          38         64    36    66                                                39
  Malignant neoplasm of intestine, except rectum                           39         114   54    114                                               48
  Accidental falls                                                         40         59    38    20[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    32[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Malignant neoplasm of breast                                             41         90    50    90                                                47
  Mental retardation                                                       42         15    29    33                                                37
  Haemolytic disease of newborn                                            43         1     26    1[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     25[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Accidents caused by firearm missiles                                     44         33    35    8[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     33[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Diseases of arteries arterioles & capillaries                            45         123   62    122                                               55
  Birth injury and difficult labour                                        46         4     27    2[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     27[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other neoplasm of lymphatic & haemotopoietic tissue                      47         89    53    89                                                50
  Other endocrine and metabolic diseases                                   48         88    56    88                                                51
  Malignant neoplasm of prostate                                           49         142   71    143                                               68
  Malignant neoplasm of larynx                                             50         131   65    131                                               63
  Injury resulting from operations of war                                  51         39    43    11[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    40[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Anoxic and hypoxic conditions not elsewhere classified                   52         6     30    24                                                44
  Enteritis and other diarrhoeal diseases                                  53         13    39    31                                                45
  Other diseases of nervous system and sense organs                        54         69    55    70                                                52
  Viral pneumonia                                                          55         75    58    76                                                56
  Infectious hepetitis                                                     56         52    51    58                                                53
  Neuroses, personality disorders & other non-psychotic mental disorders   57         74    60    75                                                61
  Empyema and abscess of lung                                              58         120   67    119                                               66
  Malignant neoplasm of bone                                               59         81    63    82                                                62
  Other nephritis and nephrosis                                            59         113   66    113                                               66
  Epilepsy                                                                 61         23    52    40                                                58
  Other bacterial diseases                                                 62         107   68    107                                               69
  Anaemias                                                                 63         19    49    36                                                57
  Conditions of placenta and cord                                          64         8     45    3[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     46[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Multiple sclerosis                                                       65         100   70    99                                                70
  Psychoses                                                                66         73    64    74                                                65
  Avitaminoses and other nutritional deficiency                            67         12    48    30                                                60
  Accidents mainly of industrial type                                      68         26    59    5[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     54[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other congenital anomalies of circulatory system                         69         11    47    28                                                59
  Meningitis                                                               70         25    61    42                                                64
  Tuberculosis of respiratory system                                       71         112   73    112                                               72
  Malignant neoplasm of skin                                               72         116   75    116                                               75
  Other malignant neoplasm of uterus                                       73         94    74    94                                                73
  Other diseases of musculoskeletal system and connective tissue           74         70    69    71                                                71
  Malignant neoplasm of cervix uteri                                       75         122   76    122                                               76
  Gastritis and duodenitis                                                 76         118   80    118                                               77
  Intestinal obstruction and hernia                                        76         76    72    77                                                74
  Cholelithiasis and cholecystitis                                         78         119   84    119                                               78
  Malignant neoplasm of buccal cavity & pharynx                            79         124   89    124                                               83
  Chronic rheumatic heart disease                                          80         102   83    102                                               79
  Acute nephritis                                                          81         104   85    104                                               81
  Other tuberculosis including late effects                                82         92    95    92                                                88
  Appendicitis                                                             82         61    77    63                                                80
  Malignant neoplasm of rectum & rectosigmoid junction                     84         125   101   125                                               95
  Peptic ulcer                                                             84         117   99    117                                               92
  Viral encephalitis                                                       86         35    79    49                                                84
  Tuberculosis of meninges and central nervous system                      87         98    102   98                                                99
  Other helminthiasis                                                      87         21    78    38                                                84
  Other viral diseases                                                     89         36    81    50                                                86
  Hyperplasia of prostate                                                  89         143   118   145                                               112
  Other complication of pregnancy, childbirth and the puerperium           91         45    87    13[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    81[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Other diseases of skin and subcutaneous tissue                           91         46    87    55                                                87
  Hypertrophy of tonsils and adenoids                                      93         68    96    69                                                94
  Typhoid fever                                                            94         91    107   91                                                103
  Bacillary dysentery and amoebiasis                                       94         18    82    35                                                88
  Influenza                                                                94         42    90    53                                                91
  Non-toxic goitre                                                         97         53    93    59                                                92
  Whooping cough                                                           98         138   116   138                                               110
  Infections of skin and subcutaneous tissue                               98         84    106   84                                                103
  Streptococcal sore throat and acarlet fever                              100        29    94    44                                                97
  Calculus of urinary system                                               101        111   113   111                                               110
  Haemorrohage of pregnancy and childbirth                                 101        37    97    9[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     90[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Spina bifidia                                                            103        63    105   65                                                105
  Paratyphoid fever & other salmonela infections                           104        27    98    43                                                102
  Ancylostomiasis                                                          104        14    91    32                                                99
  Active rheumatic fever                                                   104        51    102   57                                                105
  Cleft palate and cleft lip                                               104        1     85    21                                                97
  Tuberculosis of intestines peritoneum and mesenteric glands              108        80    110   81                                                109
  Other and unspecified abortion                                           108        28    100   6[\*](#tfn4-ijph-39-042){ref-type="table-fn"}     95[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Diphtheria                                                               110        10    91    27                                                101
  Otitis media and mastoiditis                                             110        109   118   109                                               118
  Non-articular rheumatism and rheumatism unspecified                      110        97    117   97                                                118
  Cholera                                                                  113        55    108   60                                                108
  Tuberculosis of bones and joints                                         113        85    115   85                                                115
  Measles                                                                  113        24    102   41                                                107
  Arthritis & spondylitis                                                  113        127   126   127                                               124
  Leprosy                                                                  117        66    112   68                                                115
  Hydatidosis                                                              117        86    118   86                                                120
  Thyrotoxicosis with or without goitre                                    117        83    118   83                                                120
  Brucellosis                                                              120        65    118   67                                                122
  Tetanus                                                                  120        20    109   37                                                112
  Acute poliomyelitis                                                      120        34    110   47                                                115
  Malaria                                                                  120        79    125   80                                                124
  Sepsis of childbirth and the puerperium                                  120        67    118   29[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    112[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Late effect of acute poliomyelitis                                       125        22    113   39                                                122
  Syphilis of cenral nervous system                                        125        109   128   109                                               127
  Inflammatory diseases of eye                                             125        121   128   121                                               127
  Osteomyelitis and periostitis                                            128        40    118   51                                                124
  Other syphilis                                                           129        129   134   129                                               131
  Cataract                                                                 129        133   137   133                                               137
  Glaucoma                                                                 129        93    133   93                                                131
  Meningococcal infection                                                  132        60    127   62                                                127
  Gonococcal infections                                                    132        108   137   108                                               137
  Diseases of breast                                                       132        106   134   106                                               131
  Diseases of teeth and supporting structures                              135        47    128   56                                                130
  Toxaemias of pregnancy and the puerperium                                135        41    131   52                                                131
  Ankylosis and acquired musculoskeletal deformities                       135        62    131   64                                                131
  Filarial infection                                                       138        77    137   78                                                139
  Delivery without mention of complication                                 138        56    134   18[\*](#tfn4-ijph-39-042){ref-type="table-fn"}    131[\*](#tfn4-ijph-39-042){ref-type="table-fn"}
  Anthrax                                                                  140        78    140   79                                                140
  Erysipelas                                                               140        140   144   140                                               142
  Schistosomiasis                                                          140        71    140   72                                                140
  Plague                                                                   143        146   145   146                                               145
  Smallpox                                                                 143        146   145   146                                               145
  Yellow fever                                                             143        146   145   146                                               145
  Typhus and other rickettsioses                                           143        146   145   146                                               145
  Trypanosomiasis                                                          143        146   145   146                                               145
  Relapsing fever                                                          143        146   145   146                                               145
  Congenital syphilis                                                      143        16    143   34                                                142
  Early syphilis, symptomatic                                              143        1     142   21                                                142
  Abortion induced for legal indications                                   143        145   145   144[\*](#tfn4-ijph-39-042){ref-type="table-fn"}   145[\*](#tfn4-ijph-39-042){ref-type="table-fn"}

Notes: For entries marked with

values of the corresponding Disc LLE and Disc EYLL were not lagged.

###### 

Nonparametric tests of mortality risk ranking

  **Test**                                       **Probability of death**   **LLE**   **EYLL**
  ---------------------------------------------- -------------------------- --------- ----------
  Coefficient of correlation *r*                 0.9727                     0.6923    0.9734
  Spearman rank correlation coefficient *r~s~*   0.9722                     0.6861    0.9728
  z-score                                        11.87                      8.38      11.88
  Mann-Whitney U                                 −0.058                     −0.351    −0.074

###### 

Aggregation of causes

  **Group**   **Condition**                                                **Condition(s) in [Table 3](#t3-ijph-39-042){ref-type="table"}**
  ----------- ------------------------------------------------------------ ------------------------------------------------------------------
  1           Infectious and parasitic diseases                            1--44
  2           Neoplasm (Cancer)                                            45--61
  3           Endocrine, nutritional and metabolic disease                 62--66
  4           Blood disorders and blood forming organs                     67--68
  5           Mental disorders                                             69--71
  6           Disorders of the nervous system                              72--79
  7           Diseases of the circulatory system                           80--88
  8           Diseases of the respiratory system                           89--96
  9           Diseases of the digestive system                             97--104
  10          Genitourinary disorders                                      105--111
  11          Complications of pregnancy, child birth and the puerperium   112--118
  12          Skin and sub-tissue disorders                                119--120
  13          Diseases of the musculoskeletal system                       121--125
  14          Congenital anomalies                                         126--130
  15          Prenatal disorders                                           131--135
  16          Accidents and poisoning                                      138--150
  17          Senility without mention of psychosis (old age)              136
  18          Unspecified                                                  137,151
